Paper39201255
An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects.
Stefàno E and 6 others. Int J Mol Sci, 2024. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects. Papers, record 39201255. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39201255
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- An Overview of Altered Pathways Associated with Sensitivity to Platinum-Based Chemotherapy in Neuroendocrine Tumors: Strengths and Prospects.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neuroendocrine Tumors | Major topic |
| Humans | |
| Antineoplastic Agents | |
| Carboplatin | |
| Cisplatin | |
| Signal Transduction | |
| Antineoplastic Combined Chemotherapy Protocols | |
| Platinum | |
| DNA Repair |
Source PubMed
References229
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28161703 | Neuroendocrine Cancer, Therapeutic Strategies in G3 Cancers. | Digestion | 2017 | https://conductscience.org/library/papers/28161703 | PubMed |
| 2 | 27816207 | Loss of DPC4/SMAD4 expression in primary gastrointestinal neuroendocrine tumors is associated with cancer-related death after resection. | Surgery | 2017 | https://conductscience.org/library/papers/27816207 | PubMed |
| 3 | 28497778 | PTEN regulates glioblastoma oncogenesis through chromatin-associated complexes of DAXX and histone H3.3. | Nat Commun | 2017 | https://conductscience.org/library/papers/28497778 | PubMed |
| 4 | 26251638 | Etoposide induces cell death via mitochondrial-dependent actions of p53. | Cancer Cell Int | 2015 | https://conductscience.org/library/papers/26251638 | PubMed |
| 5 | 8805928 | Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow up. | Ann Oncol | 1996 | https://conductscience.org/library/papers/8805928 | PubMed |
| 6 | 20407018 | Focal adhesion kinase, a downstream mediator of Raf-1 signaling, suppresses cellular adhesion, migration, and neuroendocrine markers in BON carcinoid cells. | Mol Cancer Res | 2010 | https://conductscience.org/library/papers/20407018 | PubMed |
| 7 | 14576837 | Cisplatin: mode of cytotoxic action and molecular basis of resistance. | Oncogene | 2003 | https://conductscience.org/library/papers/14576837 | PubMed |
| 8 | 31098602 | Unexpected therapeutic effects of cisplatin. | Metallomics | 2019 | https://conductscience.org/library/papers/31098602 | PubMed |
| 9 | 23042098 | MAPK signaling in cisplatin-induced death: predominant role of ERK1 over ERK2 in human hepatocellular carcinoma cells. | Carcinogenesis | 2013 | https://conductscience.org/library/papers/23042098 | PubMed |
| 10 | 26703889 | Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study. | Lancet | 2016 | https://conductscience.org/library/papers/26703889 | PubMed |
| 11 | 23239809 | Synergistic effect of olaparib with combination of cisplatin on PTEN-deficient lung cancer cells. | Mol Cancer Res | 2013 | https://conductscience.org/library/papers/23239809 | PubMed |
| 12 | 30968324 | Notch pathway in small-cell lung cancer: from preclinical evidence to therapeutic challenges. | Cell Oncol (Dordr) | 2019 | https://conductscience.org/library/papers/30968324 | PubMed |
| 13 | 25837868 | The p53 network as therapeutic target in gastroenteropancreatic neuroendocrine neoplasms. | Cancer Treat Rev | 2015 | https://conductscience.org/library/papers/25837868 | PubMed |
| 14 | 22343668 | Signaling pathways as specific pharmacologic targets for neuroendocrine tumor therapy: RET, PI3K, MEK, growth factors, and Notch. | Neuroendocrinology | 2013 | https://conductscience.org/library/papers/22343668 | PubMed |
| 15 | 31652074 | 177Lu-DOTATATE for the treatment of gastroenteropancreatic neuroendocrine tumors. | Expert Rev Gastroenterol Hepatol | 2019 | https://conductscience.org/library/papers/31652074 | PubMed |
| 16 | 33643409 | Detection of Genetic Mutations by Next-Generation Sequencing for Predicting Prognosis of Extensive-Stage Small-Cell Lung Cancer. | J Oncol | 2020 | https://conductscience.org/library/papers/33643409 | PubMed |
| 17 | 17522241 | Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors. | Oncologist | 2007 | https://conductscience.org/library/papers/17522241 | PubMed |
| 18 | 4176152 | Treatment of multiple-hormone-producing malignant islet-cell tumour with streptozotocin. | Lancet | 1968 | https://conductscience.org/library/papers/4176152 | PubMed |
| 19 | 28351033 | ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Systemic Therapy - Biotherapy and Novel Targeted Agents. | Neuroendocrinology | 2017 | https://conductscience.org/library/papers/28351033 | PubMed |
| 20 | 29566943 | P16 is a useful supplemental diagnostic marker of pulmonary small cell carcinoma in small biopsies and cytology specimens. | Ann Diagn Pathol | 2018 | https://conductscience.org/library/papers/29566943 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42014876 | Chidamide synergizes with cisplatin-etoposide to trigger pyroptosis and anti-tumor immunity in diffuse large B-cell lymphoma. | Commun Med (Lond) | 2026 | https://conductscience.org/library/papers/42014876 | PubMed |
| 41658779 | Neuroendocrine Neoplasms of the Gastrointestinal Tract: Morphology, WHO 2022 Grading, and Prognostic Perspectives. | Cureus | 2026 | https://conductscience.org/library/papers/41658779 | PubMed |
| 41449180 | Decoding the molecular mechanism via systems biology-based insights into neoschaftoside from Ailanthus altissima targeting lung cancer. | Sci Rep | 2025 | https://conductscience.org/library/papers/41449180 | PubMed |
| 41011719 | The Role of Metallodrugs in Enhancing Neuroendocrine Neoplasm Therapies: The Promising Anticancer Potential of Ruthenium-Based Complexes. | Molecules | 2025 | https://conductscience.org/library/papers/41011719 | PubMed |
| 40429384 | Treatment of Pancreatic Neuroendocrine Tumors: Beyond Traditional Surgery and Targeted Therapy. | J Clin Med | 2025 | https://conductscience.org/library/papers/40429384 | PubMed |
| 40217714 | Clinicopathological Characteristics of Extrapulmonary Neuroendocrine Carcinomas: Treatment Responses and Survival Outcomes: Single-Center Experience. | J Clin Med | 2025 | https://conductscience.org/library/papers/40217714 | PubMed |
| 39502104 | Prognostic Expression Signature of RB1, PTEN, and TP53 Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors. | Eur Urol Open Sci | 2024 | https://conductscience.org/library/papers/39502104 | PubMed |
| 39339356 | Metal-Based Drug-DNA Interactions and Analytical Determination Methods. | Molecules | 2024 | https://conductscience.org/library/papers/39339356 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BRCA1 | 672 | PubTator's text mining | https://conductscience.org/library/genes/672 | NCBI Gene |
| MDM2 | 4193 | PubTator's text mining | https://conductscience.org/library/genes/4193 | NCBI Gene |
| PTEN | 5728 | PubTator's text mining | https://conductscience.org/library/genes/5728 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39201255
GET https://conductscience.org/api/papers/v1/39201255/references?page=2